Stroke patients admitted to the hospital with low magnesium levels in their blood are more likely to die or have worse recovery outcomes than those with normal levels, indicating magnesium levels may help predict how badly the stroke affected them.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review and meta-analysis of RCTs could determine whether correcting low magnesium after stroke improves survival or functional recovery.
A systematic review and meta-analysis of at least 6 double-blind RCTs involving adults with acute ischemic stroke and serum magnesium <0.7 mmol/L, randomized to IV magnesium sulfate (2g over 1 hour, then 1g/hour for 24h) vs placebo, with primary outcome being modified Rankin Scale score at 90 days, secondary outcomes including mortality, hematoma growth, and serum magnesium levels.
A large RCT could determine whether magnesium supplementation after stroke improves survival or functional recovery.
A multicenter, double-blind, placebo-controlled RCT with 1,200 adults admitted within 12 hours of ischemic stroke onset and serum magnesium <0.7 mmol/L, randomized to IV magnesium sulfate (2g bolus + 1g/hour for 24h) or saline placebo, with primary outcome being modified Rankin Scale score at 90 days, secondary outcomes including NIHSS change, mortality, and serum magnesium kinetics.
A prospective cohort study could assess whether baseline magnesium levels predict stroke severity and recovery trajectory.
A prospective cohort study following 2,000 adults admitted with acute ischemic stroke, measuring serum magnesium within 6 hours of admission and tracking daily NIHSS scores, length of stay, and 90-day functional outcomes (mRS), adjusting for age, stroke subtype, comorbidities, and medications.
A cross-sectional study could identify whether stroke patients with poor outcomes have lower magnesium levels than those with better outcomes.
A cross-sectional study comparing serum magnesium levels at 72 hours post-stroke in 400 patients with poor functional outcome (mRS 3-6) and 400 with good outcome (mRS 0-2), controlling for time since stroke, age, and stroke severity at admission.
Case reports could document rare instances where rapid magnesium correction after stroke was associated with unexpected improvement in neurological function.
A case series of 10 patients with acute ischemic stroke and serum magnesium <0.6 mmol/L who received IV magnesium sulfate within 6 hours, documenting daily NIHSS changes, serum magnesium levels, and 30-day functional outcomes.